Shares of Aetna (NYSE:AET) have earned a consensus recommendation of “Hold” from the sixteen research firms that are currently covering the stock, Marketbeat reports. Nine research analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average twelve-month price objective among analysts that have issued a report on the stock in the last year is $199.17.
Several research analysts have weighed in on the stock. ValuEngine lowered shares of Aetna from a “buy” rating to a “hold” rating in a research note on Friday, June 1st. Cantor Fitzgerald raised shares of Aetna from a “neutral” rating to an “overweight” rating in a research note on Tuesday, May 1st. Zacks Investment Research raised shares of Aetna from a “sell” rating to a “hold” rating in a research note on Thursday, May 3rd. Finally, Credit Suisse Group reduced their price target on shares of Aetna from $208.00 to $194.00 and set a “neutral” rating on the stock in a research report on Monday, May 14th.
Aetna traded down $2.55, hitting $186.95, during mid-day trading on Friday, Marketbeat reports. 1,351,571 shares of the company were exchanged, compared to its average volume of 2,322,416. The company has a debt-to-equity ratio of 0.47, a current ratio of 0.73 and a quick ratio of 0.73. The firm has a market cap of $61.99 billion, a PE ratio of 18.96, a price-to-earnings-growth ratio of 1.60 and a beta of 0.62. Aetna has a 12-month low of $149.69 and a 12-month high of $194.40.
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, August 1st. Stockholders of record on Wednesday, July 25th will be given a dividend of $0.50 per share. The ex-dividend date of this dividend is Tuesday, July 24th. This represents a $2.00 annualized dividend and a dividend yield of 1.07%. Aetna’s dividend payout ratio is presently 20.28%.
Institutional investors and hedge funds have recently modified their holdings of the company. Farallon Capital Management LLC acquired a new stake in Aetna in the fourth quarter valued at approximately $940,734,000. Summit Trail Advisors LLC raised its holdings in Aetna by 55,803.4% in the first quarter. Summit Trail Advisors LLC now owns 1,616,727 shares of the company’s stock valued at $1,617,000 after acquiring an additional 1,613,835 shares in the last quarter. Wells Fargo & Company MN raised its holdings in Aetna by 101.0% in the first quarter. Wells Fargo & Company MN now owns 2,797,748 shares of the company’s stock valued at $472,819,000 after acquiring an additional 1,405,859 shares in the last quarter. Abrams Capital Management L.P. acquired a new stake in Aetna in the first quarter valued at approximately $233,220,000. Finally, Deutsche Bank AG raised its holdings in Aetna by 57.5% in the fourth quarter. Deutsche Bank AG now owns 2,704,723 shares of the company’s stock valued at $487,900,000 after acquiring an additional 987,156 shares in the last quarter. 84.92% of the stock is currently owned by institutional investors and hedge funds.
Aetna Inc operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment offers medical, pharmacy benefit management service, dental, behavioral health, and vision plans on an insured and employer-funded basis.
Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.